For example, in current DMD therapies, although inhibiting MMP-9 can improve muscle fiber regeneration, leakage of local inhibition may lead to fibrosis in other tissues, causing both inconsistent therapeutic effects and potential side effects [131]. Here, MMP9 is linked to Duchenne muscular dystrophy.